NHS Tightens Rules: Who Gets Weight-Loss Jabs Now Depends on Your Postcode
📡 119 · 1 min read ·
Part of composite article North Korea Advances Missile and Submarine Programs Amid Rising Tensions View full article →
New rules for weight-loss drugs like Wegovy are causing a "postcode lottery" across England. Local health officials are making it harder to qualify for these medicines on the NHS, despite national guidelines.
The National Institute for Health and Care Excellence (NICE) says adults with a Body Mass Index (BMI) of 35 and one weight-related health issue, like diabetes, should be eligible. However, many regional NHS groups are setting stricter limits.
Some areas now require a BMI of 40, or a BMI of 35 with *two* health conditions. Others demand that patients first complete a 12-month weight management program.
Health leaders say they must control costs and ensure the drugs go to those who need them most. The injected medications, called GLP-1 receptor agonists, are effective but expensive and must be taken long-term.
This creates a clear divide between national policy and local budgeting decisions. Patients with identical health profiles may now get different treatments depending solely on where they live.